{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T11:18:27Z","timestamp":1787051907693,"version":"build-2736575974"},"reference-count":83,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007195","name":"Universit\u00e0 degli Studi di Napoli Federico II","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007195","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","interventional.theclinics.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Interventional Cardiology Clinics"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.iccl.2024.07.001","type":"journal-article","created":{"date-parts":[[2024,8,3]],"date-time":"2024-08-03T20:25:40Z","timestamp":1722716740000},"page":"527-541","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Antiplatelet Therapy in Patients Requiring Oral Anticoagulation and Undergoing Percutaneous Coronary Intervention"],"prefix":"10.1016","volume":"13","author":[{"given":"Lina","family":"Manzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Florimonte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imma","family":"Forzano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Buongiorno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Sperandeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico Simone","family":"Castiello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Paolillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Giugliano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Giacoppo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Sciahbasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Plinio","family":"Cirillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Esposito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Gargiulo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"38","key":"10.1016\/j.iccl.2024.07.001_bib1","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1093\/eurheartj\/ehad191","article-title":"2023 ESC Guidelines for the management of acute coronary syndromes","volume":"44","author":"Byrne","year":"2023","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.iccl.2024.07.001_bib2","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/eurheartj\/ehz425","article-title":"2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes","volume":"41","author":"Knuuti","year":"2020","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.iccl.2024.07.001_bib3","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/eurheartj\/ehy394","article-title":"2018 ESC\/EACTS Guidelines on myocardial revascularization","volume":"40","author":"Neumann","year":"2019","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.iccl.2024.07.001_bib4","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/eurheartj\/ehx419","volume":"39","author":"Valgimigli","year":"2018","journal-title":"Eur Heart J"},{"issue":"6","key":"10.1016\/j.iccl.2024.07.001_bib5","doi-asserted-by":"crossref","first-page":"717","DOI":"10.4244\/EIJ-D-17-00468","article-title":"State of the art: duration of dual antiplatelet therapy after percutaneous coronary intervention and coronary stent implantation - past, present and future perspectives","volume":"13","author":"Gargiulo","year":"2017","journal-title":"EuroIntervention"},{"issue":"7","key":"10.1016\/j.iccl.2024.07.001_bib6","first-page":"2524","article-title":"Cardiovascular mortality in patients with acute and chronic coronary syndrome: insights from the clinical evidence on ticagrelor","volume":"26","author":"Gargiulo","year":"2022","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"1","key":"10.1016\/j.iccl.2024.07.001_bib7","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4244\/EIJ-E-23-00051","article-title":"Should we routinely use ultrasound-guided transfemoral access for coronary procedures? High-quality evidence from an individual participant data meta-analysis","volume":"20","author":"Gargiulo","year":"2024","journal-title":"EuroIntervention"},{"issue":"15","key":"10.1016\/j.iccl.2024.07.001_bib8","first-page":"1266","article-title":"Pharmacodynamic effects of cangrelor in elective complex PCI: insights from the POMPEII Registry","volume":"18","author":"Gargiulo","year":"2023","journal-title":"EuroIntervention"},{"issue":"18","key":"10.1016\/j.iccl.2024.07.001_bib9","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1161\/CIRCULATIONAHA.122.061527","article-title":"Effects on Mortality and Major Bleeding of Radial Versus Femoral Artery Access for Coronary Angiography or Percutaneous Coronary Intervention: Meta-Analysis of Individual Patient Data From 7 Multicenter Randomized Clinical Trials","volume":"146","author":"Gargiulo","year":"2022","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.iccl.2024.07.001_bib10","doi-asserted-by":"crossref","first-page":"e971","DOI":"10.4244\/EIJ-D-21-00441","article-title":"Prediction of radial crossover in acute coronary syndromes: derivation and validation of the MATRIX score","volume":"17","author":"Gragnano","year":"2021","journal-title":"EuroIntervention"},{"issue":"10","key":"10.1016\/j.iccl.2024.07.001_bib11","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1016\/j.amjcard.2018.07.040","article-title":"Meta-Analysis of the Impact of Strut Thickness on Outcomes in Patients With Drug-Eluting Stents in a Coronary Artery","volume":"122","author":"Iantorno","year":"2018","journal-title":"Am J Cardiol"},{"issue":"14","key":"10.1016\/j.iccl.2024.07.001_bib12","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1016\/j.jacc.2015.05.085","article-title":"Meta-Analyses of Dual Antiplatelet Therapy Following Drug-Eluting Stent Implantation: Do Bleeding and Stent Thrombosis Weigh Similar on Mortality?","volume":"66","author":"Capodanno","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"23","key":"10.1016\/j.iccl.2024.07.001_bib13","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1161\/CIRCULATIONAHA.116.023952","article-title":"A\u00a0Critical Appraisal of Aspirin in Secondary Prevention: Is Less More?","volume":"134","author":"Gargiulo","year":"2016","journal-title":"Circulation"},{"issue":"21","key":"10.1016\/j.iccl.2024.07.001_bib14","article-title":"Escalation and De-Escalation of Antiplatelet Therapy after Acute Coronary Syndrome or PCI: Available Evidence and Implications for Practice","volume":"11","author":"Gragnano","year":"2022","journal-title":"J\u00a0Clin Med"},{"issue":"2","key":"10.1016\/j.iccl.2024.07.001_bib15","first-page":"99","article-title":"[New frontiers in antiplatelet therapy: guided therapy and de-escalation after acute coronary syndrome or percutaneous coronary intervention]","volume":"24","author":"Gragnano","year":"2023","journal-title":"G\u00a0Ital Cardiol"},{"key":"10.1016\/j.iccl.2024.07.001_bib16","doi-asserted-by":"crossref","first-page":"i5483","DOI":"10.1136\/bmj.i5483","article-title":"Short term versus long term dual antiplatelet therapy after implantation of drug eluting stent in patients with or without diabetes: systematic review and meta-analysis of individual participant data from randomised trials","volume":"355","author":"Gargiulo","year":"2016","journal-title":"BMJ"},{"issue":"14","key":"10.1016\/j.iccl.2024.07.001_bib17","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.4244\/EIJV16I14A202","article-title":"Consolidating the value of the standardised ARC-HBR definition","volume":"16","author":"Gargiulo","year":"2021","journal-title":"EuroIntervention"},{"issue":"5","key":"10.1016\/j.iccl.2024.07.001_bib18","doi-asserted-by":"crossref","first-page":"371","DOI":"10.4244\/EIJ-D-20-00052","article-title":"Validation of the Academic Research Consortium for High Bleeding Risk (ARC-HBR) criteria in patients undergoing percutaneous coronary intervention and comparison with contemporary bleeding risk scores","volume":"16","author":"Ueki","year":"2020","journal-title":"EuroIntervention"},{"issue":"38","key":"10.1016\/j.iccl.2024.07.001_bib19","doi-asserted-by":"crossref","first-page":"3743","DOI":"10.1093\/eurheartj\/ehaa671","article-title":"Validation of high bleeding risk criteria and definition as proposed by the academic research consortium for high bleeding risk","volume":"41","author":"Corpataux","year":"2020","journal-title":"Eur Heart J"},{"issue":"11","key":"10.1016\/j.iccl.2024.07.001_bib20","doi-asserted-by":"crossref","first-page":"e898","DOI":"10.4244\/EIJ-D-21-00181","article-title":"Impact of clinical presentation on bleeding risk after percutaneous coronary intervention and implications for the ARC-HBR definition","volume":"17","author":"Gragnano","year":"2021","journal-title":"EuroIntervention"},{"issue":"12","key":"10.1016\/j.iccl.2024.07.001_bib21","doi-asserted-by":"crossref","first-page":"e021965","DOI":"10.1161\/JAHA.121.021965","article-title":"Sex-Based Differences in Bleeding Risk After Percutaneous Coronary Intervention and Implications for the Academic Research Consortium High Bleeding Risk Criteria","volume":"10","author":"Spirito","year":"2021","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"10","key":"10.1016\/j.iccl.2024.07.001_bib22","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1161\/CIR.0000000000000659","article-title":"Heart Disease and Stroke Statistics-2019 Update: A Report From the American Heart Association","volume":"139","author":"Benjamin","year":"2019","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.iccl.2024.07.001_bib23","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1161\/CIRCULATIONAHA.113.005119","article-title":"Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study","volume":"129","author":"Chugh","year":"2014","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.iccl.2024.07.001_bib24","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.amjcard.2013.05.063","article-title":"Estimates of current and future incidence and prevalence of atrial fibrillation in the U.S. adult population","volume":"112","author":"Colilla","year":"2013","journal-title":"Am J Cardiol"},{"issue":"35","key":"10.1016\/j.iccl.2024.07.001_bib25","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1093\/eurheartj\/eht280","article-title":"Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060","volume":"34","author":"Krijthe","year":"2013","journal-title":"Eur Heart J"},{"issue":"9","key":"10.1016\/j.iccl.2024.07.001_bib26","doi-asserted-by":"crossref","first-page":"e24964","DOI":"10.1371\/journal.pone.0024964","article-title":"Incidence and severity of coronary artery disease in patients with atrial fibrillation undergoing first-time coronary angiography","volume":"6","author":"Kralev","year":"2011","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.iccl.2024.07.001_bib27","first-page":"148","article-title":"Clinical features and in-hospital mortality associated with different types of atrial fibrillation in patients with acute coronary syndrome with and without ST elevation","volume":"66","author":"Gonz\u00e1lez-Pacheco","year":"2015","journal-title":"J\u00a0Cardiol"},{"issue":"2","key":"10.1016\/j.iccl.2024.07.001_bib28","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/j.ijcard.2012.12.057","article-title":"Unrecognized myocardial infarction and risk of atrial fibrillation: the Rotterdam Study","volume":"168","author":"Krijthe","year":"2013","journal-title":"Int J Cardiol"},{"issue":"1","key":"10.1016\/j.iccl.2024.07.001_bib29","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jacc.2019.05.016","article-title":"Management of Antithrombotic Therapy in Atrial Fibrillation Patients Undergoing PCI: JACC State-of-the-Art Review","volume":"74","author":"Capodanno","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"12","key":"10.1016\/j.iccl.2024.07.001_bib30","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.iccl.2024.07.001_bib31","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"11","key":"10.1016\/j.iccl.2024.07.001_bib32","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"22","key":"10.1016\/j.iccl.2024.07.001_bib33","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1056\/NEJMoa1310907","article-title":"Edoxaban versus warfarin in patients with atrial fibrillation","volume":"369","author":"Giugliano","year":"2013","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.iccl.2024.07.001_bib34","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.iccl.2024.07.001_bib35","first-page":"120","article-title":"Risk factors for venous and arterial thrombosis","volume":"9","author":"Previtali","year":"2011","journal-title":"Blood Transfus"},{"issue":"Suppl C","key":"10.1016\/j.iccl.2024.07.001_bib36","first-page":"C27","article-title":"The influence of shear stress on in-stent restenosis and thrombosis","volume":"4","author":"Wentzel","year":"2008","journal-title":"EuroIntervention"},{"issue":"9586","key":"10.1016\/j.iccl.2024.07.001_bib37","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0140-6736(07)61233-1","article-title":"Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial","volume":"370","author":"Mant","year":"2007","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.iccl.2024.07.001_bib38","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1093\/europace\/eut333","article-title":"Atrial fibrillation patients do not benefit from acetylsalicylic acid","volume":"16","author":"Sj\u00e4lander","year":"2014","journal-title":"Europace"},{"issue":"9526","key":"10.1016\/j.iccl.2024.07.001_bib39","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(06)68845-4","article-title":"Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial","volume":"367","author":"Connolly","year":"2006","journal-title":"Lancet"},{"issue":"20","key":"10.1016\/j.iccl.2024.07.001_bib40","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1161\/01.CIR.98.20.2126","article-title":"Randomized evaluation of anticoagulation versus antiplatelet therapy after coronary stent implantation in high-risk patients: the multicenter aspirin and ticlopidine trial after intracoronary stenting (MATTIS)","volume":"98","author":"Urban","year":"1998","journal-title":"Circulation"},{"issue":"16","key":"10.1016\/j.iccl.2024.07.001_bib41","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1161\/01.CIR.98.16.1597","article-title":"Randomized multicenter comparison of conventional anticoagulation versus antiplatelet therapy in unplanned and elective coronary stenting. The full anticoagulation versus aspirin and ticlopidine (fantastic) study","volume":"98","author":"Bertrand","year":"1998","journal-title":"Circulation"},{"issue":"23","key":"10.1016\/j.iccl.2024.07.001_bib42","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1056\/NEJM199812033392303","article-title":"A\u00a0clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators","volume":"339","author":"Leon","year":"1998","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.iccl.2024.07.001_bib43","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ijcard.2020.05.024","article-title":"Commentary: Temporarily omitting oral anticoagulants early after stenting for acute coronary syndromes patients with atrial fibrillation","volume":"318","author":"Limbruno","year":"2020","journal-title":"Int J Cardiol"},{"issue":"9872","key":"10.1016\/j.iccl.2024.07.001_bib44","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/S0140-6736(12)62177-1","article-title":"Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial","volume":"381","author":"Dewilde","year":"2013","journal-title":"Lancet"},{"issue":"16","key":"10.1016\/j.iccl.2024.07.001_bib45","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1016\/j.jacc.2015.02.050","article-title":"Duration of Triple Therapy in Patients Requiring Oral Anticoagulation After Drug-Eluting Stent Implantation: The ISAR-TRIPLE Trial","volume":"65","author":"Fiedler","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"25","key":"10.1016\/j.iccl.2024.07.001_bib46","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1056\/NEJMoa1611594","article-title":"Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI","volume":"375","author":"Gibson","year":"2016","journal-title":"N\u00a0Engl J Med"},{"issue":"16","key":"10.1016\/j.iccl.2024.07.001_bib47","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1056\/NEJMoa1708454","article-title":"Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation","volume":"377","author":"Cannon","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.iccl.2024.07.001_bib48","doi-asserted-by":"crossref","first-page":"474","DOI":"10.4244\/EIJ-D-20-00799","article-title":"Dual antithrombotic therapy with dabigatran in patients with atrial fibrillation after percutaneous coronary intervention for ST-segment elevation myocardial infarction: a post hoc analysis of the randomised RE-DUAL PCI trial","volume":"17","author":"Zeymer","year":"2021","journal-title":"EuroIntervention"},{"issue":"10206","key":"10.1016\/j.iccl.2024.07.001_bib49","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/S0140-6736(19)31872-0","article-title":"Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation (ENTRUST-AF PCI): a randomised, open-label, phase 3b trial","volume":"394","author":"Vranckx","year":"2019","journal-title":"Lancet"},{"issue":"16","key":"10.1016\/j.iccl.2024.07.001_bib50","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1056\/NEJMoa1817083","article-title":"Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation","volume":"380","author":"Lopes","year":"2019","journal-title":"N\u00a0Engl J Med"},{"issue":"20","key":"10.1016\/j.iccl.2024.07.001_bib51","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1161\/CIRCULATIONAHA.120.046534","article-title":"Risk\/Benefit Tradeoff of Antithrombotic Therapy in Patients With Atrial Fibrillation Early and Late After an Acute Coronary Syndrome or Percutaneous Coronary Intervention: Insights From AUGUSTUS","volume":"141","author":"Alexander","year":"2020","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.iccl.2024.07.001_bib52","doi-asserted-by":"crossref","first-page":"e303","DOI":"10.4244\/EIJ-D-21-00703","article-title":"Dual versus triple antithrombotic therapy after percutaneous coronary intervention: the prospective multicentre WOEST 2 Study","volume":"18","author":"Bor","year":"2022","journal-title":"EuroIntervention"},{"issue":"8","key":"10.1016\/j.iccl.2024.07.001_bib53","doi-asserted-by":"crossref","first-page":"e656","DOI":"10.4244\/EIJ-D-21-01044","article-title":"Antithrombotic strategy variability in atrial fibrillation and obstructive coronary disease revascularised with percutaneous coronary intervention: primary results from the AVIATOR 2 international registry","volume":"18","author":"Chandrasekhar","year":"2022","journal-title":"EuroIntervention"},{"issue":"3","key":"10.1016\/j.iccl.2024.07.001_bib54","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1093\/ehjcvp\/pvaa088","article-title":"Combinations of antithrombotic therapies prescribed after percutaneous coronary intervention in patients with acute coronary syndromes and atrial fibrillation: data from the nationwide MATADOR-PCI registry","volume":"7","author":"De Luca","year":"2021","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"issue":"11","key":"10.1016\/j.iccl.2024.07.001_bib55","first-page":"738","article-title":"Design of the PERSEO Registry on the management of patients treated with oral anticoagulants and coronary stent","volume":"23","author":"Sciahbasi","year":"2022","journal-title":"J\u00a0Cardiovasc Med (Hagerstown)"},{"key":"10.1016\/j.iccl.2024.07.001_bib56","doi-asserted-by":"crossref","unstructured":"Sciahbasi A, De Rosa S, Gargiulo G, et al. J Cardiovasc Pharmacol. 2024 Jul 19. https:\/\/doi.org\/10.1097\/FJC.0000000000001607. Online ahead of print. PMID: 39028879.","DOI":"10.1097\/FJC.0000000000001607"},{"issue":"46","key":"10.1016\/j.iccl.2024.07.001_bib57","doi-asserted-by":"crossref","first-page":"3757","DOI":"10.1093\/eurheartj\/ehz732","volume":"40","author":"Gargiulo","year":"2019","journal-title":"Eur Heart J"},{"issue":"FI1","key":"10.1016\/j.iccl.2024.07.001_bib58","doi-asserted-by":"crossref","first-page":"f50","DOI":"10.1093\/ehjcvp\/pvaa116","volume":"7","author":"Gargiulo","year":"2021","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"issue":"17","key":"10.1016\/j.iccl.2024.07.001_bib59","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1093\/eurheartj\/ehaa076","article-title":"Higher risk of stent thrombosis with double therapy with direct oral anticoagulants: cherry picking the populations of interest does not help","volume":"41","author":"Gargiulo","year":"2020","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.iccl.2024.07.001_bib60","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1093\/ehjcvp\/pvaa141","article-title":"The multiplication of loaves and fishes approach: a critic to double anti-thrombotics or to double number of ischaemic events?","volume":"7","author":"Gargiulo","year":"2021","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"issue":"10227","key":"10.1016\/j.iccl.2024.07.001_bib61","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/S0140-6736(20)30033-7","article-title":"Antithrombotic treatment strategies after PCI - Authors\u2019 reply","volume":"395","author":"Vranckx","year":"2020","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.iccl.2024.07.001_bib62","article-title":"Antithrombotic Therapy Optimization in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention","volume":"13","author":"Gragnano","year":"2023","journal-title":"J\u00a0Clin Med"},{"issue":"47","key":"10.1016\/j.iccl.2024.07.001_bib63","doi-asserted-by":"crossref","first-page":"4497","DOI":"10.1093\/eurheartj\/ehaa617","article-title":"Edoxaban in atrial fibrillation patients with percutaneous coronary intervention by acute or chronic coronary syndrome presentation: a pre-specified analysis of the ENTRUST-AF PCI trial","volume":"41","author":"Vranckx","year":"2020","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.iccl.2024.07.001_bib64","doi-asserted-by":"crossref","first-page":"e008349","DOI":"10.1161\/CIRCINTERVENTIONS.119.008349","article-title":"Effect of Lesion Complexity and Clinical Risk Factors on the Efficacy and Safety of Dabigatran Dual Therapy Versus Warfarin Triple Therapy in Atrial Fibrillation After Percutaneous Coronary Intervention: A Subgroup Analysis From the REDUAL PCI Trial","volume":"13","author":"Berry","year":"2020","journal-title":"Circ Cardiovasc Interv"},{"issue":"16","key":"10.1016\/j.iccl.2024.07.001_bib65","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1016\/j.jcin.2019.05.050","article-title":"Renal Function and Outcomes With Dabigatran Dual Antithrombotic Therapy in Atrial Fibrillation Patients After PCI","volume":"12","author":"Hohnloser","year":"2019","journal-title":"JACC Cardiovasc Interv"},{"issue":"23","key":"10.1016\/j.iccl.2024.07.001_bib66","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1016\/j.jcin.2019.07.059","article-title":"Dabigatran Dual Therapy Versus Warfarin Triple Therapy Post-PCI in Patients With Atrial Fibrillation and Diabetes","volume":"12","author":"Maeng","year":"2019","journal-title":"JACC Cardiovasc Interv"},{"issue":"3","key":"10.1016\/j.iccl.2024.07.001_bib67","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1093\/ehjcvp\/pvaa135","article-title":"Antithrombotic therapy according to baseline bleeding risk in patients with atrial fibrillation undergoing percutaneous coronary intervention: applying the PRECISE-DAPT score in RE-DUAL PCI","volume":"8","author":"Costa","year":"2022","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"issue":"14","key":"10.1016\/j.iccl.2024.07.001_bib68","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1016\/j.jacc.2020.01.054","article-title":"Stent Thrombosis With Dual Antithrombotic Therapy in Atrial Fibrillation-ACS\/PCI Trials","volume":"75","author":"Galli","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"10","key":"10.1016\/j.iccl.2024.07.001_bib69","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1161\/CIRCULATIONAHA.112.114967","article-title":"Bleeding after initiation of multiple antithrombotic drugs, including triple therapy, in atrial fibrillation patients following myocardial infarction and coronary intervention: a nationwide cohort study","volume":"126","author":"Lamberts","year":"2012","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.iccl.2024.07.001_bib70","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/s41569-018-0049-1","article-title":"Aspirin-free strategies in cardiovascular disease and cardioembolic stroke prevention","volume":"15","author":"Capodanno","year":"2018","journal-title":"Nat Rev Cardiol"},{"issue":"4","key":"10.1016\/j.iccl.2024.07.001_bib71","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/s41569-019-0314-y","article-title":"Dual-pathway inhibition for secondary and tertiary antithrombotic prevention in cardiovascular disease","volume":"17","author":"Capodanno","year":"2020","journal-title":"Nat Rev Cardiol"},{"issue":"16","key":"10.1016\/j.iccl.2024.07.001_bib72","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1016\/j.jcin.2021.07.005","article-title":"Aspirin Monotherapy After BioFreedom Stent and 1-Month DAPT: Is Less More Even in Low-Risk Patients?","volume":"14","author":"Gargiulo","year":"2021","journal-title":"JACC Cardiovasc Interv"},{"issue":"4","key":"10.1016\/j.iccl.2024.07.001_bib73","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/eurheartj\/ehaa739","volume":"42","author":"Giacoppo","year":"2021","journal-title":"Eur Heart J"},{"issue":"18","key":"10.1016\/j.iccl.2024.07.001_bib74","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1056\/NEJMoa2108749","article-title":"Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk","volume":"385","author":"Valgimigli","year":"2021","journal-title":"N\u00a0Engl J Med"},{"issue":"15","key":"10.1016\/j.iccl.2024.07.001_bib75","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1161\/CIRCULATIONAHA.121.056680","article-title":"Abbreviated Antiplatelet Therapy in Patients at High Bleeding Risk With or Without Oral Anticoagulant Therapy After Coronary Stenting: An Open-Label, Randomized, Controlled Trial","volume":"144","author":"Smits","year":"2021","journal-title":"Circulation"},{"issue":"9921","key":"10.1016\/j.iccl.2024.07.001_bib76","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","article-title":"Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials","volume":"383","author":"Ruff","year":"2014","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.iccl.2024.07.001_bib77","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1055\/s-0041-1726298","article-title":"Single, Dual, and Triple Antithrombotic Therapy in Cancer Patients with Coronary Artery Disease: Searching for Evidence and Personalized Approaches","volume":"47","author":"Santoro","year":"2021","journal-title":"Semin Thromb Hemost"},{"issue":"5","key":"10.1016\/j.iccl.2024.07.001_bib78","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1161\/CIRCULATIONAHA.118.036768","article-title":"Open-Label Randomized Trial Comparing Oral Anticoagulation With and Without Single Antiplatelet Therapy in Patients With Atrial Fibrillation and Stable Coronary Artery Disease Beyond 1 Year After Coronary Stent Implantation","volume":"139","author":"Matsumura-Nakano","year":"2019","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.iccl.2024.07.001_bib79","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1056\/NEJMoa1904143","article-title":"Antithrombotic Therapy for Atrial Fibrillation with Stable Coronary Disease","volume":"381","author":"Yasuda","year":"2019","journal-title":"N\u00a0Engl J Med"},{"issue":"19","key":"10.1016\/j.iccl.2024.07.001_bib80","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1093\/eurheartj\/ehz059","article-title":"Dabigatran dual therapy with ticagrelor or clopidogrel after percutaneous coronary intervention in atrial fibrillation patients with or without acute coronary syndrome: a subgroup analysis from the RE-DUAL PCI trial","volume":"40","author":"Oldgren","year":"2019","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.iccl.2024.07.001_bib81","doi-asserted-by":"crossref","first-page":"oead134","DOI":"10.1093\/ehjopen\/oead134","article-title":"Ticagrelor or prasugrel vs. clopidogrel in patients with atrial fibrillation undergoing percutaneous coronary intervention for myocardial infarction","volume":"4","author":"Godtfredsen","year":"2024","journal-title":"European heart journal open"},{"issue":"5","key":"10.1016\/j.iccl.2024.07.001_bib82","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.jacc.2020.09.011","volume":"77","author":"Kumbhani","year":"2021","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.iccl.2024.07.001_bib83","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/j.jacc.2021.09.006","article-title":"2021 ACC\/AHA\/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"79","author":"Lawton","year":"2022","journal-title":"J\u00a0Am Coll Cardiol"}],"container-title":["Interventional Cardiology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221174582400066X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221174582400066X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,8]],"date-time":"2024-09-08T22:56:10Z","timestamp":1725836170000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221174582400066X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":83,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S221174582400066X"],"URL":"https:\/\/doi.org\/10.1016\/j.iccl.2024.07.001","relation":{},"ISSN":["2211-7458"],"issn-type":[{"value":"2211-7458","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antiplatelet Therapy in Patients Requiring Oral Anticoagulation and Undergoing Percutaneous Coronary Intervention","name":"articletitle","label":"Article Title"},{"value":"Interventional Cardiology Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.iccl.2024.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}